显微镜下多血管炎中髓过氧化物酶/HLA II类分子复合物被自身抗体识别
本研究探讨HLA II类分子在显微镜下多血管炎(MPA)患者中性粒细胞表面髓过氧化物酶(MPO)表达中的作用。研究发现MPO与HLA-DR结合形成复合物表达于细胞表面,该复合物可被MPO-ANCA识别,且自身抗体结合与HLA-DR等位基因 conferred 的疾病易感性相关。MPO-HLA II类复合物存在于MPA患者中性粒细胞及细胞因子刺激的健康供者中性粒细胞中,MPO-ANCA可刺激表达该复合物的HL-60细胞。
要点
- MPO与HLA-DR结合形成复合物表达于中性粒细胞表面,可被MPO-ANCA识别。
- MPO/HLA-DR复合物表达隐蔽自身抗体表位,其抗体结合与HLA-DR等位基因疾病易感性相关。
- MPO-HLA II类复合物见于MPA患者中性粒细胞及细胞因子刺激的健康供者中性粒细胞。
核心结论
- MPO与HLA II类分子形成的复合物作为MPO-ANCA的靶点参与MPA的发病机制。
研究设计与样本
- 使用MPO和HLA-DR转染细胞以及健康供者和MPA患者的中性粒细胞分析MPO与HLA-DR的关联。
- 通过流式细胞术分析自身抗体与MPO/HLA-DR复合物的结合,采用免疫沉淀技术评估MPO与HLA-DR的关联。
- 使用表达HLA-DR和MPO的中性粒细胞样细胞系评估MPO-ANCA的功能。
主要发现
- 在HLA-DR存在下,细胞表面可检测到MPO蛋白,且MPO/HLA-DR复合物可被MPO-ANCA识别。
- 竞争抑制实验提示与HLA-DR结合的MPO表达MPO-ANCA的隐蔽自身抗体表位。
- 自身抗体与MPO/HLA-DR复合物的结合与各HLA-DR等位基因 conferred 的疾病易感性相关。
- 在MPA患者中性粒细胞以及细胞因子刺激的健康供者中性粒细胞中检测到MPO-HLA II类复合物。
- MPO-ANCA可刺激表达MPO/HLA-DR复合物的HL-60细胞。
临床怎么用
- MPO/HLA-DR复合物及针对该复合物的自身抗体可能作为MPA发病机制相关的新认识,提示HLA II类分子在MPO-ANCA自身抗体识别中的作用。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Autoantibodies against myeloperoxidase (MPO) that are expressed in neutrophils play an important role in the pathogenesis of microscopic polyangiitis (MPA). We recently observed that misfolded cellular proteins are transported to the cell surface by HLA class II molecules and are targeted by autoantibodies in patients with rheumatoid arthritis or antiphospholipid syndrome, suggesting that HLA class II molecules play an important role in autoantibody recognition. The aim of this study was to address the role of HLA class II molecules in the cell surface expression of MPO in patients with MPA. METHODS: The association of MPO with HLA-DR was analyzed using MPO and HLA-DR transfectants as well as neutrophils from healthy donors and patients with MPA. Autoantibody binding to the MPO/HLA-DR complex was analyzed by flow cytometry. The association of MPO with HLA-DR was assessed using the immunoprecipitation technique. The function of MPO-antineutrophil cytoplasmic antibody (ANCA) was assessed using a neutrophil-like cell line expressing HLA-DR and MPO. RESULTS: MPO protein was detected on the cell surface in the presence of HLA-DR, and the MPO/HLA-DR complex was recognized by MPO-ANCA. A competitive inhibition assay suggested that MPO associated with HLA-DR expresses cryptic autoantibody epitopes for MPO-ANCA. Autoantibody binding to the MPO/HLA-DR complex was correlated with disease susceptibility conferred by each HLA-DR allele, suggesting that the MPO/HLA-DR complex is involved in the pathogenicity of MPA. Indeed, MPO-HLA class II complexes were detected in neutrophils from a patient with MPA as well as in cytokine-stimulated neutrophils from healthy donors. Moreover, MPO-ANCA stimulated MPO/HLA-DR complex-expressing HL-60 cells. CONCLUSION: Our findings suggest that MPO complexed with HLA class II molecules is involved in the pathogenesis of MPA as a target for MPO-ANCA.
引用
- Hiwa R, Ohmura K, Arase N, et al. Myeloperoxidase/HLA Class II Complexes Recognized by Autoantibodies in Microscopic Polyangiitis. Arthritis Rheumatol. 2017. PMID: 28575531. doi:10.1002/art.40170
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。